Eupraxia Pharmaceuticals (X43.F) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.21
-0.18
-0.15
-0.12

Details

Expected EPS
-0.16116463702105
Actual EPS
-0.20940528226604999
Surprise EPS
-0.05
Surprise Percent
+29.93%

Description

Eupraxia Pharmaceuticals (X43.F) has reported earnings of -0.20940528226604999 per share for Q3 2025.

0 Comments

Share your thoughts